|
ZCCHC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.074100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.537800E-02 |
| Normal-vs-Stage2 |
1.170150E-02 |
| Normal-vs-Stage3 |
7.568800E-01 |
| Normal-vs-Stage4 |
1.479620E-01 |
| Stage1-vs-Stage2 |
1.213630E-01 |
| Stage1-vs-Stage3 |
1.102030E-01 |
| Stage1-vs-Stage4 |
8.632600E-01 |
| Stage2-vs-Stage3 |
1.520440E-02 |
| Stage2-vs-Stage4 |
3.655000E-01 |
| Stage3-vs-Stage4 |
2.450200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.458200E-02 |
| Normal-vs-AfricanAmerican |
1.265550E-01 |
| Normal-vs-Asian |
4.563000E-01 |
| Caucasian-vs-AfricanAmerican |
8.292800E-01 |
| Caucasian-vs-Asian |
2.627000E-01 |
| AfricanAmerican-vs-Asian |
2.959800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.212060E-02 |
| Normal-vs-Female |
2.557800E-01 |
| Male-vs-Female |
2.859200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.107600E-01 |
| Normal-vs-Extreme_Weight |
1.195840E-01 |
| Normal-vs-Obese |
7.806100E-02 |
| Normal-vs-Extreme_Obese |
5.968000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.246800E-01 |
| Normal_Weight-vs-Obese |
2.893600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.056380E-01 |
| Extreme_Weight-vs-Obese |
6.903200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.370800E-01 |
| Obese-vs-Extreme_Obese |
3.758200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.450380E-01 |
| Normal-vs-Age(41-60Yrs) |
1.964520E-03 |
| Normal-vs-Age(61-80Yrs) |
2.278600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.957600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.725000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.516400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.826980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.548400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.325600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.652600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.604000E-04 |
| Normal-VS-Type2 PRCC |
3.622200E-01 |
| Normal-VS-KIRP CIMP |
9.952200E-01 |
| Normal-VS-Unclassified PRCC |
3.022400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.79891999999571E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.302790E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.857400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.571800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.363600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.530300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.478000E-01 |
| Normal-vs-N1 |
6.684200E-01 |
| Normal-vs-N2 |
2.039600E-01 |
| N0-vs-N1 |
7.813600E-01 |
| N0-vs-N2 |
2.597000E-01 |
| N1-vs-N2 |
3.270600E-01 |
|
|
